28 Expanding the Use of GLP-1-Based Therapies Beyond Obesity Although primarily used for obesity treatment, GLP-1 agonists and multi-receptor therapies may have broader applications in metabolic disease management
Thus, integration of both hormones into a single molecule may not only maximize the metabolic efficacy of the individual signals, but allow also specific delivery of estrogen into GLP1 receptor-expressing cells, avoiding potential undesired effects of estrogen on reproductive tissues, as shown also in our studies
Among the mechanisms that determine disease severity, immature molecular response and defense systems at the intestinal epithelial cell (IEC) are implicated
Vegan, allergen-free, and backed by FDA and FSSAI approvals, its the smart choice for professionals seeking a youthful, glowing complexion from within
Epidemiology and Risk Factors Prevalence and Demographics CSVD affects millions of individuals worldwide, with prevalence increasing dramatically with age
